Firvanq (vancomycin hydrochloride for oral solution) is an antibacterial used for the treatment ofClostridium difficile-associated diarrhea andenterocolitiscaused byStaphylococcus aureus(including methicillin-resistant strains) in adults and pediatric patients. Fact Table Formula C66H76Cl3N9O24 License US FDA, EU EMA Bioavailability less than 10% Legal status Rx-Only Chemical Name Vancomycin HCL Elimination half-life 4 to 6 hours Dosage (Strength) 25 mg/ml, 50 mg/ml Pregnancy not recommended Brands Firvanq Protein binding 55% PubChem CID 6420023 MedlinePlus a604038 ChEBI 9932 ATC code J01XA01 DrugBank DB00512 KEGG D00926 Routes of administration Oral
Firvanq (Vancomycin Hydrochloride)
- Each kit of Firvanq consists of vancomycin hydrochloride USP, powder for oral solution, equivalent to 3.75 grams or 7.5 grams or 15.0 grams vancomycin, and grape-flavored diluent. Clostridium difficile-associated diarrhea: Adults (18 years and older): 125 mg by mouth four times daily for 10 days, Pediatrics (less than 18 years old): 40 mg per kg by mouth in 3 or 4 divided doses for 7 to 10 days. Do not exceed 2,000 mg daily. Enterocolitis caused byStaphylococcus aureus: Adults (18 years and older): 500 mg to 2,000 mg by mouth in 3 or 4 divided doses for 7 to 10 days., Pediatrics (less than 18 years old): 40 mg per kg by mouth in 3 or 4 divided doses for 7 to 10 days. Do not exceed 2,000 mg daily. Shake Firvanq oral solution well before each dose. Use a measuring device to measure out the appropriate dose (in milliliters). Store Firvanq in the refrigerator. Discard Firvanq after 14 days or if it looks cloudy or has particulates.
